Abstract
1 In an acute study in hypertensive patients with normal and decreased renal function the i.v. administration of pindolol (0.1 mg/kg) caused a decrease in inulin clearance and a concomitant but not significant decrease in PAH clearance with a constant filtration fraction. 2 The long-term administration of pindolol (5--20 mg/day) to hypertensive patients with normal renal function was not associated with changes in renal function but in patients with a decreased renal function, pindolol caused an increase in PAH clearance but no change in inulin clearance.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Atterhög J. H., Dunér H., Pernow B. Experience with pindolol, a betareceptor blocker, in the treatment of hypertension. Am J Med. 1976 May 31;60(6):872–876. doi: 10.1016/0002-9343(76)90907-4. [DOI] [PubMed] [Google Scholar]
- Bauer J. H., Brooks C. S. The long-term effect of propranolol therapy on renal function. Am J Med. 1979 Mar;66(3):405–410. doi: 10.1016/0002-9343(79)91059-3. [DOI] [PubMed] [Google Scholar]
- Heierli C., Thoelen H., Radielovic P. Renal function following a single dose of pindolol in hypertensive patients with varying degrees of impairment of renal function. Int J Clin Pharmacol Biopharm. 1977 Feb;15(2):65–71. [PubMed] [Google Scholar]
- Ibsen H., Sederberg-Olsen P. Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension. Clin Sci. 1973 Feb;44(2):129–134. doi: 10.1042/cs0440129. [DOI] [PubMed] [Google Scholar]
- Nies A. S., McNeil J. S., Schrier R. W. Mechanism of increased sodium reabsorption during propranolol administration. Circulation. 1971 Oct;44(4):596–604. doi: 10.1161/01.cir.44.4.596. [DOI] [PubMed] [Google Scholar]
- Wainer E., Boner G., Rosenfeld J. B. Effects of pindolol on renal function. Clin Pharmacol Ther. 1980 Nov;28(5):575–580. doi: 10.1038/clpt.1980.205. [DOI] [PubMed] [Google Scholar]